Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Related structures:
AlphaFold database: Q4QF07
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 35 | 37 | PF00675 | 0.426 |
CLV_NRD_NRD_1 | 68 | 70 | PF00675 | 0.554 |
CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.433 |
CLV_PCSK_KEX2_1 | 63 | 65 | PF00082 | 0.513 |
CLV_PCSK_KEX2_1 | 68 | 70 | PF00082 | 0.488 |
CLV_PCSK_PC1ET2_1 | 63 | 65 | PF00082 | 0.498 |
CLV_PCSK_PC7_1 | 64 | 70 | PF00082 | 0.514 |
CLV_PCSK_SKI1_1 | 122 | 126 | PF00082 | 0.434 |
CLV_PCSK_SKI1_1 | 26 | 30 | PF00082 | 0.565 |
CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.454 |
DEG_APCC_DBOX_1 | 114 | 122 | PF00400 | 0.483 |
DEG_APCC_DBOX_1 | 68 | 76 | PF00400 | 0.567 |
DEG_SPOP_SBC_1 | 163 | 167 | PF00917 | 0.533 |
DOC_CYCLIN_RxL_1 | 117 | 130 | PF00134 | 0.486 |
DOC_CYCLIN_RxL_1 | 63 | 73 | PF00134 | 0.447 |
DOC_MAPK_gen_1 | 117 | 126 | PF00069 | 0.481 |
DOC_MAPK_MEF2A_6 | 120 | 128 | PF00069 | 0.490 |
DOC_PP1_RVXF_1 | 24 | 30 | PF00149 | 0.412 |
DOC_USP7_MATH_1 | 144 | 148 | PF00917 | 0.532 |
DOC_USP7_MATH_1 | 163 | 167 | PF00917 | 0.550 |
DOC_USP7_MATH_1 | 44 | 48 | PF00917 | 0.535 |
DOC_USP7_MATH_1 | 91 | 95 | PF00917 | 0.567 |
DOC_USP7_UBL2_3 | 39 | 43 | PF12436 | 0.522 |
DOC_WW_Pin1_4 | 140 | 145 | PF00397 | 0.592 |
DOC_WW_Pin1_4 | 75 | 80 | PF00397 | 0.551 |
LIG_14-3-3_CanoR_1 | 64 | 72 | PF00244 | 0.445 |
LIG_deltaCOP1_diTrp_1 | 182 | 191 | PF00928 | 0.506 |
LIG_FHA_1 | 165 | 171 | PF00498 | 0.745 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.530 |
LIG_FHA_1 | 76 | 82 | PF00498 | 0.587 |
LIG_FHA_1 | 94 | 100 | PF00498 | 0.490 |
LIG_FHA_2 | 2 | 8 | PF00498 | 0.583 |
LIG_MYND_1 | 140 | 144 | PF01753 | 0.589 |
LIG_SH2_NCK_1 | 30 | 34 | PF00017 | 0.476 |
LIG_SH2_SRC | 30 | 33 | PF00017 | 0.612 |
LIG_SH2_STAT3 | 10 | 13 | PF00017 | 0.493 |
LIG_SH3_3 | 76 | 82 | PF00018 | 0.548 |
LIG_TRAF2_1 | 132 | 135 | PF00917 | 0.566 |
MOD_CDK_SPK_2 | 75 | 80 | PF00069 | 0.484 |
MOD_CK1_1 | 143 | 149 | PF00069 | 0.607 |
MOD_CK1_1 | 165 | 171 | PF00069 | 0.534 |
MOD_CK1_1 | 47 | 53 | PF00069 | 0.530 |
MOD_CK1_1 | 94 | 100 | PF00069 | 0.479 |
MOD_CK2_1 | 128 | 134 | PF00069 | 0.498 |
MOD_GlcNHglycan | 130 | 133 | PF01048 | 0.533 |
MOD_GlcNHglycan | 155 | 159 | PF01048 | 0.705 |
MOD_GlcNHglycan | 96 | 99 | PF01048 | 0.531 |
MOD_GSK3_1 | 140 | 147 | PF00069 | 0.522 |
MOD_GSK3_1 | 161 | 168 | PF00069 | 0.675 |
MOD_GSK3_1 | 174 | 181 | PF00069 | 0.464 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.586 |
MOD_NEK2_1 | 198 | 203 | PF00069 | 0.490 |
MOD_PK_1 | 80 | 86 | PF00069 | 0.590 |
MOD_PKA_1 | 63 | 69 | PF00069 | 0.514 |
MOD_PKA_2 | 174 | 180 | PF00069 | 0.589 |
MOD_PKA_2 | 63 | 69 | PF00069 | 0.514 |
MOD_Plk_1 | 134 | 140 | PF00069 | 0.540 |
MOD_Plk_1 | 6 | 12 | PF00069 | 0.480 |
MOD_Plk_4 | 165 | 171 | PF00069 | 0.643 |
MOD_Plk_4 | 198 | 204 | PF00069 | 0.496 |
MOD_ProDKin_1 | 140 | 146 | PF00069 | 0.593 |
MOD_ProDKin_1 | 75 | 81 | PF00069 | 0.555 |
TRG_ENDOCYTIC_2 | 30 | 33 | PF00928 | 0.442 |
TRG_ER_diArg_1 | 115 | 118 | PF00400 | 0.485 |
TRG_ER_diArg_1 | 138 | 141 | PF00400 | 0.474 |
TRG_NES_CRM1_1 | 116 | 130 | PF08389 | 0.382 |
TRG_Pf-PMV_PEXEL_1 | 122 | 127 | PF00026 | 0.588 |
TRG_Pf-PMV_PEXEL_1 | 69 | 73 | PF00026 | 0.455 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0H3 | Leptomonas seymouri | 32% | 100% |
A0A3Q8IIW8 | Leishmania donovani | 80% | 100% |
A4HWR2 | Leishmania infantum | 81% | 100% |
E9AQG9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 78% | 100% |